Feed / TBRG

TruBridge Inc

TBRG

Healthcare · 26.25 +0.0% today

Participation confirmed · construction unavailableMarket checked 8 Jul, 15:55 GMT-4

Market read

TruBridge Inc's move is being confirmed by its market group.

No new filing conclusion is available. 6 of 7 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 3 directly disclosed connections are confirming.

Company+0.0% todayVolume comparison unavailable
Market group6 of 7 activeDiversified Financial Services · active
Disclosed network0 of 3 confirmingNo filing-linked name is confirming now
What would change this read
  • At least 5 of 7 members remain active in the next snapshot.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as BG begins moving with the group.

Invalidation: The live read weakens if participation falls to 2 of 7 members or fewer.

Watch this read

Research brief

The story so far

Healthcare · Health Information Services

No new filing conclusion is available. 6 of 7 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 3 directly disclosed connections are confirming.

Evidence that supports

No thresholded supportive filing evidence is available yet.

Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • At least 5 of 7 members remain active in the next snapshot.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as BG begins moving with the group.

Company research

Understand the business, not just the ticker

As of Sep 11, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods6
Price observations285
Usable filing statements139
Verified relationships3
Evidence supporting the case
  • Operating margin changed +4.1 percentage points in the latest annual period.
  • Net margin changed +7.4 percentage points in the latest annual period.
  • Operating cash flow covered net income at 8.49x in the latest annual period.
Evidence challenging the case
  • Credit and interest rates has repeated adverse evidence across 4 filings.
  • Input and raw-material costs has repeated adverse evidence across 4 filings.
  • Labor availability and costs has repeated adverse evidence across 4 filings.
  • Product pipeline and R&D has repeated adverse evidence across 3 filings.
Questions before a position
  • P/E is 84% above the available filing-peer median; determine whether growth and quality justify the difference.
  • EV/sales is 46% below the available filing-peer median; determine whether growth and quality justify the difference.
Longer-term price context

Price as of Jul 13, 2026

26.24
6m+15.6%12m+14.3%24m
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2021-12-31$280.6M+5.0%$1.26+8.0%
2022-12-31$326.6M+16.4%$1.08+0.3%
2023-12-31$337.0M+3.2%$-3.32-1.2%
2024-12-31$342.2M+1.6%$-1.41+0.8%
2025-12-31$346.8M+1.4%$0.29+1.3%

What management says matters

Persistent and emerging business drivers

Credit and interest ratesnegative · 4 filings
The decrease was driven by a reduction in interest expense due to lower debt and a reduction in the interest rate.
10-Q · May 8, 2026
Demand and volumemixed · 4 filings
Bookings are reported on an Annual Contract Value (“ACV”) basis and represent the newly contracted revenue that is expected to be recognized over a twelve-month period, and were as follows for the three months ended March 31, 2026 and 2025: Three Months Ended…
10-Q · May 8, 2026
Input and raw-material costsmixed · 4 filings
Costs associated with our Patient Care revenues decreased by $1.2 million, or 10%, compared to the first quarter of 2025, primarily due to a reduction in software costs and lower labor costs as a result of cost optimization and savings efforts.
10-Q · May 8, 2026
Labor availability and costsmixed · 4 filings
Costs associated with our Patient Care revenues decreased by $1.2 million, or 10%, compared to the first quarter of 2025, primarily due to a reduction in software costs and lower labor costs as a result of cost optimization and savings efforts.
10-Q · May 8, 2026

Valuation discipline

Descriptive valuation snapshot

Price/sales 1.1× · EV/sales 1.5×. Comparisons use only industry-matched filing peers.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

26.25+0.0% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 8 Jul, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for TBRG. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Filing analysis

No comparable filing assessment is available yet

Jodie has not yet found a suitable current-versus-prior filing comparison for TBRG. This does not mean the latest filing was neutral or immaterial.

Business ecosystem

The relationships behind TBRG

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

SOLVSolventum CorporationcompetitorMar 31, 2026

The primary competitors for our encoder solutions include Solventum and Optum.

WAYWaystar Holding Corp.competitorMar 31, 2026

Our principal competitors for Financial Health solutions include RelayHealth Corp, SSI Group, LLC, Quadax Inc., Change Healthcare Holdings, Inc., Availity, LLC, Waystar Technologies, Inc., Experian, and Navicure, Inc.

XTNDFiling-linked namecompetitorMar 31, 2026

Our principal competitors in the business management, consulting and managed IT services market are Resolution Health, Inc., The Outsource Group Inc., Patient Focus, Inc., Xtend Healthcare Inc., Ensemble Health Partners, and FinThrive, Inc.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 7 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

TBRG is currently a Participant in the organic co-movement group Diversified Financial Services. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.